Research and Markets has announced the addition of the "EMRs and Clinical Research: Current and Potential Impact" report to their offering.
In this report, ISR leverages the insights and real-world experiences investigative sites have with electronic medical records (EMRs) and clinical trials. The report examines how sites currently use EMRs for various clinical trial activities and provides recommendations to improve trial efficiency.
Executive Summary:
This report provides the pharmaceutical industry and its service providers with novel insights into the current and future use of electronic medical records (EMRs) by clinical sites for clinical development.
While government incentive programs have driven the adoption of EMRs, ISR has found that investigative sites are still in the early stages of optimizing these technologies to positively impact clinical research, Andrew Schafer, President of ISR explained. ISR's newest report found that just because a medical practice has an EMR system installed, does not mean that they have integrated the system into the clinical research workflow.
The study study highlights significant opportunity for EMR vendors and trial sponsors. ISR surveyed 102 site coordinators and principal investigators with responsibility for clinical research and the analysis allows readers to:
